Cargando…
Design, Synthesis, and Functional Activity of Labeled CD1d Glycolipid Agonists
[Image: see text] Invariant natural killer T cells (iNKT cells) are restricted by CD1d molecules and activated upon CD1d-mediated presentation of glycolipids to T cell receptors (TCRs) located on the surface of the cell. Because the cytokine response profile is governed by the structure of the glyco...
Autores principales: | Jervis, Peter J., Polzella, Paolo, Wojno, Justyna, Jukes, John-Paul, Ghadbane, Hemza, Garcia Diaz, Yoel R., Besra, Gurdyal S., Cerundolo, Vincenzo, Cox, Liam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630740/ https://www.ncbi.nlm.nih.gov/pubmed/23458425 http://dx.doi.org/10.1021/bc300556e |
Ejemplares similares
-
Amide Analogues of CD1d
Agonists Modulate iNKT-Cell-Mediated Cytokine Production
por: Wojno, Justyna, et al.
Publicado: (2012) -
Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues
por: Jervis, Peter J., et al.
Publicado: (2012) -
Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
por: Jukes, John‐Paul, et al.
Publicado: (2016) -
Synthesis of a Versatile Building Block for the Preparation of 6-N-Derivatized α-Galactosyl Ceramides: Rapid Access to Biologically Active Glycolipids
por: Jervis, Peter J., et al.
Publicado: (2010) -
CD169(+) MACROPHAGES PRESENT LIPID ANTIGENS TO MEDIATE EARLY ACTIVATION OF INVARIANT NKT CELLS IN LYMPH NODES
por: Barral, Patricia, et al.
Publicado: (2010)